| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
14,440,000 |
| Market
Cap: |
398.40(M) |
| Last
Volume: |
73,763 |
Avg
Vol: |
112,501 |
| 52
Week Range: |
$16.98 - $27.65 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 798 |
| Guru Rank Value : 1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Anika Therapeutics is a global joint preservation company. Co. is focused on orthopedics, including: Osteoarthritis Pain Management, which consists of Monovisc and Orthovisc, Cingal, and Hyvisc; Joint Preservation and Restoration, which include bone preserving joint technologies, soft tissue repair and regenerative solutions; and Non-Orthopedic, which consists of Hyalobarrier, an anti-adhesion barrier indicated for use after abdomino-pelvic surgeries, Hyalomatrix, which is used for the treatment of complex wounds such as burns and ulcers, as well as products used in connection with the treatment of ears, nose and throat disorders, and ophthalmic products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
1,500 |
| Total Buy Value |
$0 |
$0 |
$0 |
$32,055 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Wheeler Steve E |
Director |
– • – |
2014-06-12 |
4 |
D |
$0.00 |
$0 |
D/D |
(22,753) |
28,869 |
|
- |
|
| Moran John C |
Director |
– • – |
2014-05-30 |
4 |
S |
$48.41 |
$96,820 |
D/D |
(2,000) |
20,292 |
|
- |
|
| Sherwood Charles H |
President and CEO |
• • – |
2014-05-05 |
4 |
D |
$47.46 |
$8,988,022 |
D/D |
(189,381) |
177,955 |
|
- |
|
| Sherwood Charles H |
President and CEO |
• • – |
2014-05-05 |
4 |
OE |
$3.05 |
$2,638,985 |
D/D |
337,530 |
367,336 |
|
- |
|
| Sherwood Charles H |
President and CEO |
• • – |
2014-05-01 |
4 |
S |
$44.32 |
$3,713,130 |
D/D |
(83,780) |
29,806 |
|
- |
|
| Sherwood Charles H |
President and CEO |
• – – |
2014-02-28 |
4 |
S |
$41.09 |
$6,163,500 |
D/D |
(150,000) |
113,586 |
|
- |
|
| Land Raymond J |
Director |
– • – |
2014-02-27 |
4 |
S |
$43.47 |
$387,492 |
D/D |
(8,914) |
13,678 |
|
- |
|
| Sherwood Charles H |
President and CEO |
• – – |
2014-02-27 |
4 |
S |
$43.53 |
$2,176,500 |
D/D |
(50,000) |
263,586 |
|
- |
|
| Thompson Jeffery S |
Director |
– • – |
2014-01-27 |
4 |
S |
$45.82 |
$474,054 |
D/D |
(10,346) |
11,076 |
|
- |
|
| Land Raymond J |
Director |
– • – |
2014-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
1,873 |
22,592 |
|
- |
|
| Cheung Sylvia |
CFO |
• – – |
2014-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
6,100 |
13,150 |
|
- |
|
| Sherwood Charles H |
Chief Executive Officer |
• – – |
2014-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
15,500 |
313,586 |
|
- |
|
| Thompson Jeffery S |
Director |
– • – |
2014-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
1,873 |
21,422 |
|
- |
|
| Barnett Carol A |
Chief Commercial Officer |
• – – |
2014-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
6,100 |
6,100 |
|
- |
|
| Wheeler Steve E |
Director |
– • – |
2014-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
1,873 |
51,622 |
|
- |
|
| Bower Joseph I |
Director |
– • – |
2014-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
1,873 |
30,542 |
|
- |
|
| Moran John C |
Director |
– • – |
2014-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
1,873 |
22,292 |
|
- |
|
| Wheeler Steve E |
Director |
– • – |
2013-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,530 |
49,749 |
|
- |
|
| Bower Joseph I |
Director |
– • – |
2013-11-20 |
4 |
A |
$0.00 |
$0 |
D/D |
1,530 |
28,669 |
|
- |
|
| Sheets John W Jr |
Chief Scientific Officer |
• – – |
2013-10-02 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
|
- |
|
| Moran John C |
Director |
– • – |
2013-08-22 |
4 |
S |
$24.35 |
$121,750 |
D/D |
(5,000) |
20,419 |
|
- |
|
| Wheeler Steve E |
Director |
– • – |
2013-08-08 |
4 |
S |
$23.61 |
$637,092 |
D/D |
(26,984) |
48,219 |
|
- |
|
| Wheeler Steve E |
Director |
– • – |
2013-08-07 |
4 |
S |
$24.99 |
$27,439 |
D/D |
(1,098) |
75,203 |
|
- |
|
| Fiore Holding S.r.l. |
10% Owner |
– – • |
2013-08-06 |
4/A |
S |
$24.52 |
$31,140,400 |
D/D |
(1,270,000) |
711,192 |
|
- |
|
| Fidia Farmaceutici S.p.a. |
10% Owner |
– – • |
2013-08-06 |
4 |
S |
$24.52 |
$31,140,400 |
D/D |
(1,270,000) |
711,192 |
|
- |
|
405 Records found
|
|
Page 9 of 17 |
|
|
